Concepedia

Publication | Open Access

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial

130

Citations

20

References

2018

Year

References

YearCitations

2011

5.3K

2007

5K

2017

3.1K

2008

2.9K

2016

2.1K

2007

2K

2011

802

2008

725

2003

701

2018

506

Page 1